Skip to content

Publications

(This page last updated June 2022)

Google Scholar Link

COVID-19 Research

  • Embury J, Tsou MH, Nara A, Oren E. A spatio-demographic perspective on the role of the social determinants of health and chronic disease in determining COVID-19 population vulnerability. In Press, Preventing Chronic Diseases, 2022.
  • Lehnig C, Oren E, Vaidya N. Effectiveness of Alternative Spring Break Schedules on Reducing COVID-19 Incidence on College Campuses. Scientific Reports, 2022. 12:2116 https://doi.org/10.1038/s41598-022-06260-1
  • Cooksey G, Morales C, Linde L, Schildhauer S, Guevara H, Chan E, et al. including Oren E.  California SARS-CoV-2 and Respiratory Virus Sentinel Surveillance (CalSRVSS) Among Patients with Mild or Asymptomatic Presentation – California, May 10, 2020–June 12, 2021. Emerging Infectious Diseases, 2022. 28(1):9-19. https://wwwnc.cdc.gov/eid/article/28/1/21-1682_article
  • Gibbons J, Yang, TC, Oren E. Community Boosts Immunity? Exploring the Relationship Between Social Capital and COVID-19 Social Distancing. Spatial Demography, 2021. https://doi.org/10.1007/s40980-021-00096-5

Asthma/Respiratory Research

  • Pulvers K, Tracy L, Hunn A, Novotny, TE, Romero DR, Satybaldiyeva N, Magraner J, Oren E. Switching People Who Smoke to Unfiltered Cigarettes: Perceptions, Addiction, and Behavioral Effects in a Cross-over Randomized Controlled Trial. Tobacco Control, 2021. 0:1–4. doi:10.1136/tobaccocontrol-2021-056815
  • Romero DR, Pulvers K, Carter E, Barber C, Satybaldiyeva N, Novotny, TE, Oren E. Naturalistic Topography Assessment in a Randomized Clinical Trial of Smoking Unfiltered Cigarettes: Challenges, Opportunities, & Recommendations. International Journal of Environmental Research and Public Health, 2021. 18: 11857.
  • Oren E, Pulvers K, Barber C, Romero DR, Novotny, TE. Design and Methods of a Randomized Cross-over Clinical Trial of Unfiltered Cigarettes on Smoking Behavior and Toxic Exposure. JMIR Research Protocols, 2020. 9(12):e19603. https://www.researchprotocols.org/2020/12/e19603
  • Oren E, Martinez FM. Stress and Asthma: Physiologic manifestations and clinical implication. Annals of Allergy, Asthma and Immunology, 2020. doi: https://doi.org/10.1016/j.anai.2020.07.022
  • Koslik HJ, Joshua J, Cuevas-Mota J, Goba D, Oren E, Alcarez JE, Garfein RS. Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California, Drug and Alcohol Dependence, 2020. 214: 108158
  • Malo, J, Holbrook E, Zangeneh T, Strawter C, Oren E, et al. Comparison of three anti-coccidioides antibody enzyme immunoassay kits for the diagnosis of coccidioidomycosis. Medical Mycology, 2020.  1-5. doi:10.1093/mmy/myz125
  • American Thoracic Society Assembly on Pediatrics including Oren E. Home Oxygen Therapy for Children: An Official ATS Clinical Practice Guideline. Am J Respir Crit Care Med, 2019.199(3):e5-e23.
  • Global Burden of Disease 2017 Lower Respiratory Infections Collaborators, including Oren E. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. The Lancet Respiratory Medicine, 2019. 7(1):69-89. https://doi.org/10.1016/S2213-2600(18)30496-X.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015:  Findings from the Global Burden of Disease 2015 study. International Journal of Public Health, 2017. doi: 10.1007/s00038-017-1007-0
  • Bime C, Fiero M, Lu Z, Oren E, Berry CE, Parthasarathy S, Garcia JGN.  High Positive End Expiratory Pressure is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome. American Journal of Medicine, 2016. http://dx.doi.org/10.1016/j.amjmed.2016.09.029 
  • Oren E, Gerald LB, Stern DA, Martinez FD, Wright AL. Self-reported Stressful Life Events during Adolescence and Asthma. JACI In Practice, 2016.  pii: S2213-2198(16)30416-0. doi: 10.1016/j.jaip.2016.09.019
  • Oren E, Rothers J, Stern, DA, Halonen M, Wright AL. Cough duration during infancy is associated with childhood asthma. Clinical & Experimental Allergy, 2015. 45(9): 1439-1446. DOI: 10.1111/cea.12573* Featured as Editor’s Choice, Clinical & Experimental Allergy, 2015. 45(9)
  • Malo J, Holbrook E, Zangeneh T, Strawter C, Oren E, Robey I, Erickson H, Chahal R, Durkin M, Thompson C, Hoover S, Ampel NM, Wheat J, Knox K. Enhanced antibody detection and diagnosis of coccidioidomycosis with the Miravista IgG and IgM antibody enzyme immunoassay Journal of Clinical Microbiology, 2017. 55: 1-9.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infectious Diseases, 2017. pii: S1473-3099(17)30396-1.

Tuberculosis Research

  • Bui D, Oren E, Brown H, Harris R, Knight GM, Grandjean L. Community Transmission of Multidrug-resistant Tuberculosis is associated with Activity Space Overlap in Lima, Peru. BMC Infectious Diseases. 2021 21:275.
  • Stoesslé P, González-Salazar F, Ayala SP, Oren, E. Tuberculosis risk factors and knowledge among undocumented migrants in Northeast Mexico. Migration and Health, 107-133.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national burden of tuberculosis from 1990 to 2016: results from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2016 Study. The Lancet Infectious Diseases, 2018. 18(12): 1329-1349.
  • Bui D, Oren E, Roe DJ, Brown H, Harris R, Knight G, Gilman R, Grandjean L. A Case Control Study to Identify Community Venues Associated with Genetically Clustered Multidrug Resistant Tuberculosis Disease in Lima, Peru. Clinical Infectious Diseases. 2018. doi: 10.1093/cid/ciy746.
  • Proaño A, Bui D, López JW, Vu NM, Bravard MA, Lee GO, Tracey BH, Xu Z, Comina G, Ticona E, Mollura DJ, Friedland JS, Moore DAJ, Evans CA, Caligiuri P, Gilman RH; Tuberculosis Working Group in Peru, including Oren E. Cough Frequency During Treatment Associated with Baseline Cavitary Volume and Proximity to the Airway in Pulmonary Tuberculosis. Chest. 2018. Mar 17. pii: S0012-3692(18)30413-6. doi: 10.1016/j.chest.2018.03.006.
  • LaCourse SM, Cranmer LM, Bekker A, Steingart KR, Black D, Horne DJ, Oren E, Pals S, Modi S, Mathad J. Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012934. DOI: 10.1002/14651858.CD012934.
  • Oren E, Bell ML, Garcia F, Perez-Velez C, Gerald LB. Promoting Adherence to Treatment for Latent TB Infection through Mobile Phone Text Messaging: Study Protocol for a Pilot Randomized Controlled Trial. Pilot and Feasibility Trials, 2017. 3(15) DOI: 10.1186/s40814-017-0128-9.
  • Jamil SM, Oren E, Garrison GW, Srikanth S, Lewinsohn DM, Wilson KC, Thomson CC. Clinical Practice Guideline: Summary for Clinicians - Diagnosis of Tuberculosis in Adults and Children. Annals of the American Thoracic Society, 2017.  14(2): 275-8.
  • Oren E, Fiero M, Nuῆez M, Barrett E, Hawkins E, Gonzalez-Salazar F. Detection of latent tuberculosis infection among migrant farmworkers. BMC Infectious Diseases, 2016. 16:630. DOI 10.1186/s12879-016-1959-3
  • Osuchukwu O, Blust R, Nuῆez M, Ehiri J, Rosales C, Hawkins E, Aviles J, Gonzalez-Salazar F, Oren E. Acceptability of Latent Tuberculosis Infection Screening among Migrant Farmworkers in Yuma-San Luis, Arizona. International Migration, 2017. 55(5): 62-74.
  • Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Oren E et al. Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.  Plos One. 2016. 11(5):e0155968.
  • Oren E, Alatorre-Isaguirre G, Vargas-Villareal J, Moreno Trevino M, Garcialuna-Martinez J, Gonzalez-Salazar F. Interferon gamma-based detection of latent tuberculosis infection in the border states of Nuevo Leon and Tamaulipas, Mexico.  Frontiers in Public Health. 2015; September 30. http://dx.doi.org/10.3389/fpubh.2015.00220.
  • Oppong J, Mayer J, Oren E. The Global Health Threat of African Urban Slums: The Example of Urban Tuberculosis. African Geographical Review, 2014. DOI: 10.1080/19376812.2014.91081
  • Li Y, Ehiri J, Oren E, Hu D, Luo X, Liu  Y, Wang Q.. Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China. PLOS One, 2014. 9(2):e88330.
  • Campo M, Shrestha A, Oren E, Thiede H, Duchin J, Narita M, Crothers K.  Characterization of Hepatitis C Co-infected Tuberculosis Patients in an Urban City in the US. Epidemiology and Infection, 2013. Sep 25:1-8.
  • Lindquist S, Ghosh-Chatterjee S, Field K, Allen S, Narita M, Oren E. Public Health Prioritization of TB Genotype Clusters. Emerging Infectious Diseases, 2013; 19(3): 493-495.
  • Horne D, Campo M, Arentz M, Oren E, Crothers K, Narita M. Association between Smoking and Latent Tuberculosis in the U.S. Population. PLOS One, 2012;7(11):e49050.
  • Barry PM, Shaw T, Oren E, Field K, Funk E, Langer AJ, Gardner TJ. Multistate Outbreak of Multidrug-Resistant Tuberculosis Identified by Genotype Cluster Investigation among Foreign-Born Seafood Production Workers. Emerging Infectious Diseases, 2012; 18(1): 113-116.
  • Oren E, Winston CA, Pratt R, Robison VA, Narita M. Epidemiology of Urban Tuberculosis in the United States, 2000-2007. American Journal of Public Health. 2011; 101:1256-1263.
  • Horne D, Oren E, Spitters CE, Johnson C, Narita M. How Soon can Smear Positive Tuberculosis Patients be Released from Inpatient Isolation? Infection Control and Hospital Epidemiology. 2010; 31(1): 78-84.
  • Parimon T, Spitters CE, Muangman N, Euathrongchit J, Oren E, Narita M. Unexpected Pulmonary Involvement in Extrapulmonary Tuberculosis Patients. Chest. 2008; 134(3): 589-594.
  • Ashworth M,  Horan KL, Freeman R, Oren E, Narita M, Cangelosi GA. Use of PCR-based Mycobacterium tuberculosis Genotyping to Prioritize Tuberculosis Outbreak Control Activities. Journal of Clinical Microbiology. 2008; 46(3):856-862.
  • Oeltmann JE, Oren E, Haddad MB, Lake LK, Harrington T, Ijaz K, Narita M. Tuberculosis Outbreak in Marijuana Users, Seattle, Washington, 2004. Emerging Infectious Diseases. 2006; 12(7):1156-1159.
  • Freeman R, Kato-Maeda M, Hauge KA, Oren E, Narita M, Wallis CK, Nolan C, Small PM, Cangelosi GA. Use of Rapid Genomic Deletion Typing to Monitor a Tuberculosis Outbreak within an Urban Homeless Population. Journal of Clinical Microbiology. 2005; 43(11):5550-5554.

H. pylori and Cancer Research

  • Harris RB, Brown HE, Begay R, Sanderson P, Chief C, Monroy F, Oren E. Helicobacter pylori prevalence and risk factors in three rural indigenous communities of Northern Arizona. Int. J. Environ. Res. Public Health 2022, 19(2), 797; https://doi.org/10.3390/ijerph19020797
  • Chief C, Yazzie A, Sanderson P, McKinley A, Willeto A, Trujillo J, Harris R, Oren E. "Nobody is talking about it”: Diné (Navajo) communities speak about stomach cancer and Helicobacter pylori infections. Journal of Cancer Education, 2020. https://doi.org/10.1007/s13187-020-01831-0
  • Florea A, Brown H, Harris RB, Oren E. Ethnic Disparities in Gastric Cancer Presentation and Screening Practice in the US: An Analysis of 1997-2010 SEER-Medicare Data. Cancer Epidemiology, Biomarkers and Prevention. 2019. 28 (4): 659-665.
  • Gupta S, Tao L, Murphy J, Constanza Camargo, M, Oren E, Valasek M, Gomez S, Martinez ME. Race, Ethnicity, Socioeconomic Status and Anatomic Subsite-specific Risk for Gastric Cancer. Gastroenterology. 2018. pii: S0016-5085(18)35041-8. DOI: 10.1053/j.gastro.2018.09.045
  • Kohler LN, Harris RB, Oren E, Roe DJ, Lance P, Jacobs ET. Adherence to nutrition and physical activity cancer prevention guidelines and development of colorectal adenoma. Nutrients. 2018. 10, 1098; doi:10.3390/nu10081098
  • Driscoll L, Harris R, Brown HE, Oren E. Population Knowledge, Attitude and Practice regarding Helicobacter pylori Transmission and Outcomes: A Literature Review. Frontiers in Public Health, 2017. 5:144. doi: 10.3389/fpubh.2017.0014
  • Murakami T, Scranton R, Brown H, Harris RB, Chen Z, Musuku S, Oren E. Management of Helicobacter Pylori in the United States: Results from a National Survey of Gastroenterology Physicians. Preventive Medicine, 2017. 100: 216-222.
  • Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer Epidemiology, Biomarkers and Prevention. 2016. 25(7): 1018-1028.
  • Bui D, Harris RB, Brown H, Oren E. The Association between Helicobacter pylori and Hepatitis A in the United States: Serologic Evidence for Fecal-oral Transmission of H. pylori from the National Health and Nutrition Examination Surveys.  American Journal of Tropical Medicine & Hygiene, Published online November 23, 2015; doi:10.4269/ajtmh.15-0297
  • Kohler LN, Hibler EA, Harris RB, Oren E, Roe DJ, Jurutka PW, Jacobs ET. Greater adherence to cancer prevention guidelines is associated with higher circulating concentrations of vitamin D metabolites in a cross-sectional analysis of pooled participants from two chemoprevention trials. Journal of Nutrition, 2017. doi: 10.3945/jn.116.243352
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 2016. doi:10.1001/jamaoncol.2016.5688

Vaccine Research

  • Haenchen S, Jacobs B, Pottinger H, Oren E, Ernst K. Perceptions of Personal Belief Vaccine Exemption Policy: A Survey of Arizona Vaccine Providers. Vaccine, 2014. DOI: 10.1016/j.vaccine.2014.04.081

Social Epidemiology Research

  • Savin KL, Roesch SC, Oren E, Carlson JA et al. Social and Built Neighborhood Environments and Blood Pressure 6 Years Later: Results from HCHS/SOL and the SOL CASAS Ancillary Study. Social Science & Medicine, 2021. https://doi.org/10.1016/j.socscimed.2021.114496
  • Valdez LA, Garcia DO, Ruiz J, Oren E, Carvajal S. Understanding Social and Cultural Contexts of Alcohol Abuse in Mexican-Origin Hispanic Men. Health Education & Behavior, 2019.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Alcohol use and burden: a systematic analysis from the Global Burden of Disease Study 2016 for 195 countries and territories, 1990–2016. The Lancet. 2018. 392 (10152): 1015-35.
  • Valdez LA, Garcia DO, Ruiz J, Oren E, Carvajal S. Exploring Structural, Sociocultural, and Individual Barriers to Alcohol Abuse Treatment Among Hispanic Men. American Journal of Men’s Health. 2018. doi: 10.1177/1557988318790882.
  • Valdez LA, Flores M, Garcia DO, Ruiz J, Oren E, Carvajal S. Gender and Cultural Adaptations for Diversity: A Systematic Review of Alcohol and Substance Abuse Interventions for Latino Males. Substance Use and Abuse, 2018. 24:1-16.https://doi.org/10.1080/10826084.2017.1417999
  • Li Y, Ehiri J, Hu D, Oren E, Cao J.. Framework of behavioral indicators for outcome evaluation of TB health promotion: a Delphi study of TB policy makers and health workers. Infectious Diseases of Poverty. 2015; 4(1). DOI:10.1186/s40249-015-0087-4
  • Oren E, Koepsell T, Leroux B, Mayer J. Area-based Socioeconomic Disadvantage and Tuberculosis Incidence. International Journal of the Union against TB and Lung Disease, 2012; 16(7):880-5
  • Oren E, Narita M, Nolan C, Mayer J. Neighborhood socioeconomic position and tuberculosis transmission: a retrospective cohort study. BMC Infectious Diseases, 2014.14:227.
  • Colvin C, Mugyabuso J, Munuo G, Lyimo J, Oren E, et al. Evaluation of community based interventions to improve TB case detection in Tanzania. Global Health: Science and Practice, 2014. 2(2): 219-225.
  • Oren E, Narita M, Nolan C, Mayer J. The role of area-level socioeconomic disadvantage on severe pulmonary tuberculosis: U.S., 2000-2008. Public Health Reports, 2013; 128: 99-109.

Global Burden of Disease

  • GBD 2019 Tuberculosis Collaborators, including Oren E. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis, 2021 Sep 23:S1473-3099(21)00449-7.
  • GBD 2019 Tobacco Collaborators, including Oren E. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet, 2021 397(10292):2337-2360.
  • GBD 2019 Viewpoint Collaborators, including Oren E. Five insights from the Global Burden of Disease Study 2019. Lancet, 2020. 396: 1135–59.
  • Local Burden of Disease Project Collaborators, including Oren E. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17. Lancet Global Health, 2020. 8:8, e1038-e1060.
  • LBD Double Burden of Malnutrition Collaborators including Oren E. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nat Med. 2020 May;26(5):750-759. doi: 10.1038/s41591-020-0807-6. Epub 2020 Apr 20.
  • GBD Chronic Respiratory Disease Collaborators, including Oren E. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Respiratory Medicine, 2020. 8(6): 585-596
  • Global Burden of Disease Collaborators, including Oren E. The global, regional, and national burden of stomach cancer in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterology & Hepatology, 2020. 5(1):42-54 https://doi.org/10.1016/S2468-1253(19)30328-0
  • Global Burden of Disease 2017. Lower Respiratory Infections Collaborators, including Oren E. Quantifying risks and interventions to prevent and protect against lower respiratory infection health-loss among children under-5 years old: An analysis of the Global Burden of Disease study 2017. Lancet Infectious Diseases, 2020. 20:60-79. https://doi.org/10.1016/S1473-3099(19)30410-4
  • Local Burden of Disease Project Collaborators, including Oren E. Mapping 132 million neonatal, infant, and child deaths between 2000 and 2017. Nature, 2019. 574: 353–358.
  • Global Burden of Disease Study 2017 Collaborators, including Oren E.  Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018. 10;392(10159):1859-1922.
  • Global Burden of Disease 2017 Lower Respiratory Infections Collaborators, including Oren E. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. The Lancet Respiratory Medicine, 2019. 7(1):69-89. https://doi.org/10.1016/S2213-2600(18)30496-X.Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national burden of neurological disorders, 1990-2016:  a systematic analysis for the Global Burden of Disease study 2016. The Lancet Neurology. 2019. pii: S1474-4422(18)30499-X.
  • GBD 2016 Lower Respiratory Infections Collaborators, including Oren E. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018. Sep 19. pii: S1473-3099(18)30310-4. doi: 10.1016/S1473-3099(18)30310-4.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. The State of US Health: Burden of Diseases, Injuries, and Risk Factors among US States, 1990-2016. JAMA. 2018. 319(14):1444-1472.
  • Global Burden of Disease Study 2018 Collaborators, including Oren E. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet, 2018. 391 (10136):2236–71, doi: 10.1016/S0140-6736(18)30994-2.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Alcohol use and burden: a systematic analysis from the Global Burden of Disease Study 2016 for 195 countries and territories, 1990–2016. The Lancet. 2018. 392 (10152): 1015-35.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. The Lancet Infectious Diseases, 2017. (In press).
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1345-1422.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1260-1344.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1211-1259.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1151-1210.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1084-1150.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1423-1459.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infectious Diseases, 2017. pii: S1473-3099(17)30396-1.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Aug 16. pii: S2213-2600(17)30293-X.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015:  Findings from the Global Burden of Disease 2015 study. International Journal of Public Health, 2017. doi: 10.1007/s00038-017-1007-0.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Healthcare Access and Quality Index based on mortality from causes amenable to personal healthcare in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease 2015 study Lancet, 2017. 390 (10091):231–66.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 2016. doi:10.1001/jamaoncol.2016.5688
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. The Lancet HIV, 2016. 3(8): e361-87.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Measuring the health-related Sustainable Development Goals in 188 countries: A baseline analysis from the Global Burden of Disease Study  2015. The Lancet. 2016. 388 (10053): 1813-1850.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national life expectancy, all‐cause and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1459–544.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 195 countries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1659-724.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1603–58.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1725-74.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1775-812.

Other Infectious Disease Research

  • Chakravarti I, Miranda-Schaeubinger M, Ruiz-Remigio MS, Briones-Garduno C, Fernandez-Figueroa EA, Villanueva-Cabello CC, Borge-Villareal A, Bejar-Ramierez Y, Perez-Gonzalez A, Rivera-Benitez C, Oren E, Brown H, Becker I, Gilman RH. Chagas disease in pregnant women from endemic regions attending the Hospital General de Mexico, Mexico City. Tropical Medicine and Infectious Disease. 2022, 7, 8. https://doi.org/10.3390/tropicalmed7010008
  • ATS Guidelines Workgroup, Assembly of Pulmonary Infection and Tuberculosis, including Oren E. Nucleic Acid-Based Testing for Non-influenza Viral Pathogens in Adults with Suspected Community Acquired Pneumonia. Am J Respir Crit Care Med, 2021 203(9).
  • Oren E, Martinez L, Islam T, Hensley E, Jain P, Nara, A, Tsou, M. Twitter Communication during an Infectious Disease Outbreak: The Case of Hepatitis A in San Diego, 2016-2018. American Journal of Public Health, 2020. 110(S3), pp. S348–S355.
  • Brown HE, Dennis LK, Lauro P, Jain P, Pelley E, Oren E. Emerging Evidence for Infectious Causes of Cancer in the United States. Epidemiologic Reviews, 2019. doi.org/10.1093/epirev/mxz003
  • Oren E, Frere J, Yom-Tov E, Yom-Tov E. Respiratory syncytial virus tracking using internet search engine data. BMC Public Health. 2018. 18:445. https://doi.org/10.1186/s12889-018-5367-z
  • Barnes S, Wansaula Z, Herrick K, Oren E, Ernst K, Olsen S, Casal M. Mortality Estimates among Adult Patients with Severe Acute Respiratory Infections from two Sentinel Hospitals in Southern Arizona, United States, 2010-2014. BMC Infectious Diseases, 2018. 18 (78).
  • Hansen V, Oren E, Dennis L, Brown, H. Infectious Disease Mortality Trends in the United States. JAMA, 2016. 316 (20): 2149-2151.
  • GBD 2016 Lower Respiratory Infections Collaborators, including Oren E. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018. Sep 19. pii: S1473-3099(18)30310-4. doi: 10.1016/S1473-3099(18)30310-4.

Health Technology

  • Oren E, Shaffer ER and Guglielmo BJ. Impact of Emerging Technologies Upon Medication Errors and Adverse Drug Events: A Review of the Evidence. American Journal of Health-System Pharmacists 2003; 60:1447-1458.
  • Oren E, Griffiths LP and Guglielmo BJ. Demographics of Antimicrobial Overrides Associated with Automated Dispensing Machines. American Journal of Health-System Pharmacists 2002; 59 (15): 1445-1448.
  • Oren E, McCart G, Phillips KA. Evaluating the Potential Impact of Pharmacogenomics on ADRs: A Subject Review. Journal of Managed Care Pharmacy 2002; 8 (4): 285-290.
  • Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. Journal of the American Medical Association 2001; 286 (18): 2270-2279.

Systematic Reviews (may be duplicative of content area listing)

  • Valdez LA, Flores M, Garcia DO, Ruiz J, Oren E, Carvajal S. Gender and Cultural Adaptations for Diversity: A Systematic Review of Alcohol and Substance Abuse Interventions for Latino Males. Substance Use and Abuse. 2018. https://doi.org/10.1080/10826084.2017.1417999
  • LaCourse SM, Cranmer LM, Bekker A, Steingart KR, Black D, Horne DJ, Oren E, Pals S, Modi S, Mathad J. Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012934. DOI: 10.1002/14651858.CD012934.
  • Fiero M, Huang S, Oren E, Bell ML. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review. Trials. 2016; 17 (72). DOI: 10.1186/s13063-016-1201-z
  • Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer Epidemiology, Biomarkers and Prevention. 2016. 25(7): 1018-1028.
  • Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. Journal of the American Medical Association 2001; 286 (18): 2270-2279.

Other Methodology and Content

  • Richard EL, McEvoy LK, Oren E, Alcaraz JE, Laughlin GA, LaCroix, AZ, Salem, RM. Markers of Kidney Function, Genetic Variation Related to Cognitive Function and Cognitive Performance in the UK Biobank. BMC Nephrology, 2022. 23:159
  • Baker P, Beletsky L, Pitpitan E, Oren E, Strathdee SA, Cepeda JA. Impact of SHIELD Police Training on Knowledge of Syringe Possession Laws and Related Arrests in Tijuana, Mexico. American Journal of Public Health, 2022. e1-e5. https://doi.org/10.2105/AJPH.2021.306702
  • Delker E, Bandoli G, LaCoursiere Y, Ferran K, Gallo L, Oren E, Ramos G, Gahagan S, Allison M. Chronic hypertension and risk of preterm delivery: National Longitudinal Study of Adolescents to Adult Health. Journal of Pediatric and Perinatal Epidemiology, 2022. 00:1–10. https://doi.org/10.1111/ppe.12858
  • Richard EL, McEvoy LK, Cao SY, Oren E, Alcaraz JE, LaCroix, AZ, Salem, RM. Biomarkers of Kidney Function and Cognitive Ability: a Mendelian Randomization Study. Journal of the Neurological Sciences, 2021. 430:118071
  • Richard EL, McEvoy LK, Oren E, Alcaraz JE, Laughlin GA, LaCroix, AZ, Salem, RM. Markers of Kidney Function and Longitudinal Cognitive Ability Among Older Community-Dwelling Adults: The Rancho Bernardo Study. Journal of Alzheimer’s Disease, 2021. 83(1):319-331.
  • Baker P, Arredondo J, Borquez A, Clarigue E, Mittal ML, Morales M, Rocha Jimenez, T, Garfein RS, Oren E, Pitpitan E, Strathdee SA, Beletsky L, Cepeda JA. Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico. Harm Reduction Journal, 2021. 18:76.
  • Gershon AS, Lindenauer PK, Wilson KC, Rose L, Walkey AJ, Sadatsafavi M, Anstrom KJ, Au DH, Bender BG, Brookhart MA, Dweik RA, Han MK, Joo MJ, Lavergne V, Mehta AB, Miravitlles M, Mularski RA, Roche N, Oren E, Riekert KA, Schoenberg NC, Stukel TA, Weiss CH, Wunsch H, Africk JJ, Krishnan JA. Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021 Jan 1;203(1):14-23. doi: 10.1164/rccm.202010-3943ST. PMID: 33385220. 
  • ATS Committee on Observational Research Studies, including Oren E. Informing Health Care Decisions with Observational Research assessing Causal Effect:  An Official American Thoracic Society Research Statement (In Press, AJRCCM).
  • Fiero M, Huang S, Oren E, Bell ML. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review. Trials. 2016; 17 (72). DOI: 10.1186/s13063-016-1201-z
  • Oren E, Smith NL, Doggen CJ, Heckbert SR, Lematire RN. Body mass index and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost. 2006 Oct;4(10):2273-5.
  • Phillips KA, Stotland NE, Liang SY, Spetz J, Haas JS, Oren E. Out-of-pocket Expenditures for Oral Contraceptives and Number of Pill Packs Obtained per Purchase. Journal of the American Women’s Medical Association. 2004;59(1):36-42.